CRISPR & CRISPR-associated Genes Market 2027 by Product, Application, End User and Geography | The Insight Partners

CRISPR & CRISPR-associated (Cas) Genes Market to 2027 - Global Analysis and Forecasts By Product (Vector-based Cas, DNA-free Cas); Application (Genome Engineering, Disease models, Functional Genomics, Knockdown/activation, Others); End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) and Geography

Report Code: TIPRE00006876 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

CRISPR and CRISPR-Associated (Cas) Genes is a genome editing tool that enables the researchers to make changes in the DNA. CRISPR-Cas9 stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9. In recent years the CRISPR and CRISPR-Associated (Cas) Genes has gained lot of popularity as it offers it is cheaper, faster, accurate, and more efficient genome editing methods.

MARKET DYNAMICS


The CRISPR and CRISPR-associated (Cas) Genes market is anticipated to grow in the forecast, owing to the factors such as rising adoption of genome editing technique, growing adoption of CRISPR, and increasing prevalence of genetic disorders. Furthermore, increasing demand for drug discovery is likely to pose growth opportunities for the CRISPR and CRISPR-associated (Cas) Genes market to grow.

MARKET SCOPE


The "Global CRISPR and CRISPR-associated (Cas) Genes market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of CRISPR and CRISPR-associated (Cas) Genes market with detailed market segmentation by product, application, end user and geography. The global CRISPR and CRISPR-associated (Cas) Genes market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading CRISPR and CRISPR-associated (Cas) Genes market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global CRISPR and CRISPR-associated (Cas) Genes market is segmented on the basis of product, application, and end user. Based on product the market is segmented into vector-based Cas and DNA-free Cas. Based on application the market is segmented into genome engineering, disease models, functional genomics, knockdown/activation and others. Based on end user the market is segmented into biotechnology and pharmaceutical companies, academic and government research institutes, contract research organizations.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global CRISPR and CRISPR-associated (Cas) Genes market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The CRISPR and CRISPR-associated (Cas) Genes market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting CRISPR and CRISPR-associated (Cas) Genes market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the CRISPR and CRISPR-associated (Cas) Genes market in these regions.

MARKET PLAYERS


The reports cover key developments in the CRISPR and CRISPR-associated (Cas) Genes market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from CRISPR and CRISPR-associated (Cas) Genes market are anticipated to lucrative growth opportunities in the future with the rising demand for CRISPR and CRISPR-associated (Cas) Genes market in the global market. Below mentioned is the list of few companies engaged in the CRISPR and CRISPR-associated (Cas) Genes market.

The report also includes the profiles of CRISPR and CRISPR-associated (Cas) Genes market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Merck KGaA
  •  Addgene
  •  CRISPR THERAPEUTICS
  •  Thermo Fisher Scientific, Inc.
  •  Mirus Bio LLC
  •  Editas Medicine
  •  Takara Bio USA
  •  Horizon Discovery Group plc
  •  Dharmacon Inc
  •  Intellia Therapeutics, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 CRISPR & CRISPR-associated (Cas) Genes Market - By Product
1.3.2 CRISPR & CRISPR-associated (Cas) Genes Market - By Application
1.3.3 CRISPR & CRISPR-associated (Cas) Genes Market - By End User
1.3.4 CRISPR & CRISPR-associated (Cas) Genes Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - GLOBAL MARKET ANALYSIS

6.1. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - GLOBAL MARKET OVERVIEW
6.2. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT

7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. VECTOR-BASED CAS, DNA-FREE CAS
7.3.1. Overview
7.3.2. Vector-based Cas, DNA-free Cas Market Forecast and Analysis
7.4. DNA-FREE CAS
7.4.1. Overview
7.4.2. DNA-free Cas Market Forecast and Analysis

8. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GENOME ENGINEERING
8.3.1. Overview
8.3.2. Genome Engineering Market Forecast and Analysis
8.4. DISEASE MODELS
8.4.1. Overview
8.4.2. Disease models Market Forecast and Analysis
8.5. FUNCTIONAL GENOMICS
8.5.1. Overview
8.5.2. Functional Genomics Market Forecast and Analysis
8.6. KNOCKDOWN/ACTIVATION
8.6.1. Overview
8.6.2. Knockdown/activation Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Biotechnology and Pharmaceutical Companies Market Forecast and Analysis
9.4. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES
9.4.1. Overview
9.4.2. Academic and Government Research Institutes Market Forecast and Analysis
9.5. CONTRACT RESEARCH ORGANIZATIONS
9.5.1. Overview
9.5.2. Contract Research Organizations Market Forecast and Analysis

10. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America CRISPR & CRISPR-associated (Cas) Genes Market Overview
10.1.2 North America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.1.3 North America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.1.4 North America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.1.5 North America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.1.6 North America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.1.6.1 United States CRISPR & CRISPR-associated (Cas) Genes Market
10.1.6.1.1 United States CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.1.6.1.2 United States CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.1.6.1.3 United States CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.1.6.2 Canada CRISPR & CRISPR-associated (Cas) Genes Market
10.1.6.2.1 Canada CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.1.6.2.2 Canada CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.1.6.2.3 Canada CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.1.6.3 Mexico CRISPR & CRISPR-associated (Cas) Genes Market
10.1.6.3.1 Mexico CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.1.6.3.2 Mexico CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.1.6.3.3 Mexico CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.2. EUROPE
10.2.1 Europe CRISPR & CRISPR-associated (Cas) Genes Market Overview
10.2.2 Europe CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.2.3 Europe CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.2.4 Europe CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.2.5 Europe CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.2.6 Europe CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.2.6.1 Germany CRISPR & CRISPR-associated (Cas) Genes Market
10.2.6.1.1 Germany CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.2.6.1.2 Germany CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.2.6.1.3 Germany CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.2.6.2 France CRISPR & CRISPR-associated (Cas) Genes Market
10.2.6.2.1 France CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.2.6.2.2 France CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.2.6.2.3 France CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.2.6.3 Italy CRISPR & CRISPR-associated (Cas) Genes Market
10.2.6.3.1 Italy CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.2.6.3.2 Italy CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.2.6.3.3 Italy CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.2.6.4 Spain CRISPR & CRISPR-associated (Cas) Genes Market
10.2.6.4.1 Spain CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.2.6.4.2 Spain CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.2.6.4.3 Spain CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.2.6.5 United Kingdom CRISPR & CRISPR-associated (Cas) Genes Market
10.2.6.5.1 United Kingdom CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.2.6.5.2 United Kingdom CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.2.6.5.3 United Kingdom CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Overview
10.3.2 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.3.3 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.3.6.1 Australia CRISPR & CRISPR-associated (Cas) Genes Market
10.3.6.1.1 Australia CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.3.6.1.2 Australia CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.3.6.1.3 Australia CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.3.6.2 China CRISPR & CRISPR-associated (Cas) Genes Market
10.3.6.2.1 China CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.3.6.2.2 China CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.3.6.2.3 China CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.3.6.3 India CRISPR & CRISPR-associated (Cas) Genes Market
10.3.6.3.1 India CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.3.6.3.2 India CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.3.6.3.3 India CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.3.6.4 Japan CRISPR & CRISPR-associated (Cas) Genes Market
10.3.6.4.1 Japan CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.3.6.4.2 Japan CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.3.6.4.3 Japan CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.3.6.5 South Korea CRISPR & CRISPR-associated (Cas) Genes Market
10.3.6.5.1 South Korea CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.3.6.5.2 South Korea CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.3.6.5.3 South Korea CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Overview
10.4.2 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.4.3 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa CRISPR & CRISPR-associated (Cas) Genes Market
10.4.6.1.1 South Africa CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.4.6.1.2 South Africa CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.4.6.1.3 South Africa CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.4.6.2 Saudi Arabia CRISPR & CRISPR-associated (Cas) Genes Market
10.4.6.2.1 Saudi Arabia CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.4.6.2.2 Saudi Arabia CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.4.6.2.3 Saudi Arabia CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.4.6.3 U.A.E CRISPR & CRISPR-associated (Cas) Genes Market
10.4.6.3.1 U.A.E CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.4.6.3.2 U.A.E CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.4.6.3.3 U.A.E CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Overview
10.5.2 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis
10.5.3 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Product
10.5.4 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Application
10.5.5 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By End User
10.5.6 South and Central America CRISPR & CRISPR-associated (Cas) Genes Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil CRISPR & CRISPR-associated (Cas) Genes Market
10.5.6.1.1 Brazil CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.5.6.1.2 Brazil CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.5.6.1.3 Brazil CRISPR & CRISPR-associated (Cas) Genes Market by End User
10.5.6.2 Argentina CRISPR & CRISPR-associated (Cas) Genes Market
10.5.6.2.1 Argentina CRISPR & CRISPR-associated (Cas) Genes Market by Product
10.5.6.2.2 Argentina CRISPR & CRISPR-associated (Cas) Genes Market by Application
10.5.6.2.3 Argentina CRISPR & CRISPR-associated (Cas) Genes Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. CRISPR & CRISPR-ASSOCIATED (CAS) GENES MARKET, KEY COMPANY PROFILES

12.1. MERCK KGAA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ADDGENE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CRISPR THERAPEUTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. THERMO FISHER SCIENTIFIC, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MIRUS BIO LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EDITAS MEDICINE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TAKARA BIO USA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HORIZON DISCOVERY GROUP PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DHARMACON INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INTELLIA THERAPEUTICS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Merck KGaA
2. Addgene
3. CRISPR THERAPEUTICS
4. Thermo Fisher Scientific, Inc.
5. Mirus Bio LLC
6. Editas Medicine
7. Takara Bio USA
8. Horizon Discovery Group plc
9. Dharmacon Inc.
10. Intellia Therapeutics, Inc.